Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Non-Current Deffered Revenue: 2015-2025

Historic Non-Current Deffered Revenue for HUTCHMED (China) (HCM) over the last 1 years, with Jun 2025 value amounting to $30.8 million.

  • HUTCHMED (China)'s Non-Current Deffered Revenue fell 49.22% to $30.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $30.8 million, marking a year-over-year decrease of 49.22%. This contributed to the annual value of $190,000 for FY2022, which is N/A change from last year.
  • According to the latest figures from Q2 2025, HUTCHMED (China)'s Non-Current Deffered Revenue is $30.8 million, which was down 49.22% from $60.6 million recorded in Q2 2024.
  • In the past 5 years, HUTCHMED (China)'s Non-Current Deffered Revenue ranged from a high of $97.2 million in Q2 2023 and a low of $190,000 during Q4 2022.
  • In the last 3 years, HUTCHMED (China)'s Non-Current Deffered Revenue had a median value of $60.6 million in 2024 and averaged $62.9 million.
  • Data for HUTCHMED (China)'s Non-Current Deffered Revenue shows a maximum YoY tumbled of 49.22% (in 2025) over the last 5 years.
  • Quarterly analysis of 4 years shows HUTCHMED (China)'s Non-Current Deffered Revenue stood at $190,000 in 2022, then reached $97.2 million in 2023, then tumbled by 37.61% to $60.6 million in 2024, then plummeted by 49.22% to $30.8 million in 2025.
  • Its Non-Current Deffered Revenue stands at $30.8 million for Q2 2025, versus $60.6 million for Q2 2024 and $97.2 million for Q2 2023.